Clinical Trial Update: Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating fecal microbiota transplantation for nonalcoholic fatty liver disease with suspected nonalcoholic steatohepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Lifespan | Conditions: Nonalcoholic Fatty Liver Disease | Phase 1 | Status: UNKNOWN